Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07534358 · ClinicalTrials.gov registry record · NA

Intensive Case Management Between VA and Community Care for Suicide Prevention

A NA study, sponsored by VA Eastern Colorado Health Care System.

Recruiting
Registry status
NA
Development phase
100
Enrollment target

NCT07534358: Recruiting NA study, sponsored by VA Eastern Colorado Health Care System.

NCT07534358 is a NA study that is actively recruiting participants, run by VA Eastern Colorado Health Care System. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07534358, a NA study, is actively recruiting participants, sponsored by VA Eastern Colorado Health Care System.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The goal of this randomized clinical trial is to build the evidence base for SUPERCEDE, a suicide prevention focused intensive case management intervention to increase access, improve care coordination, provide suicide prevention monitoring, and procure a timely response of VA mental health and suicide prevention services among VA-enrolled veterans receiving VA authorized community care. This phase is a hybrid effectiveness Type 1 randomized control trial, which will include 2 arms: the treatment intervention, SUPERCEDE, and the control intervention, present centered therapy. The main questions it aims to answer are:• This RCT will continue to build the evidence base for effectiveness and determine feasibility and acceptability for the previously piloted SUPERCEDE. • This RCT will improve the understanding of implementation of this intervention, both in VA and VA authorized community care organizations in preparation for broader implementation. Researchers will compare SUPERCEDE and present centered therapy to see if SUPERCEDE results in improved functioning and a decrease in suicidal ideation. Participants will be randomized to either SUPERCEDE or present centered therapy (PCT) plus a safety plan if warranted. SUPERCEDE is a suicide prevention case management intervention that combines BCBT-SP, a Crisis Response Plan (CRP), intensive case management to alleviate suicide risk factors, and VA authorized community care coordination. PCT is an active control condition often used in clinical trials of posttraumatic stress disorder. The intervention focuses on the present moment and encouraging the client to find solutions to their problems. In this trial, investigators will mirror the sessions of PCT to SUPERCEDE. Thus, the control group will receive 3 sessions, with an optional 3 additional sessions. Detailed Description For hypothesis 3a: Overall, 100 participants will be randomized to either SUPERCEDE or present centered therapy (PCT) plus a safety plan if warranted

Primary Outcome

B-IPF is a 7-item measure of interpersonal functioning. Scores range from 0 (not at all) to 6 (very much), with higher scores indicating worse functioning. Investigators will fit linear mixed models for the outcome variable of functioning with the between-subject factor of treatment (SUPERCEDE vs. PCT), the within- subject factor of time, and the interaction between two factors (treatment X time). Several correlation structures will be considered for repeated measures within individuals, and the

Interventions

  • BEHAVIORAL SUicidE PRevention intensive CasE management and coorDination in Community CarE (SUPERCEDE)
  • BEHAVIORAL Present centered therapy

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-08-01
Est. Completion 2027-06
Phase NA

What NCT07534358 shows while recruiting

NCT07534358 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which SUicidE PRevention intensive CasE management and coorDination in Community CarE (SUPERCEDE) is the first listed.

NCT07534358 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07534358 about?

NCT07534358 is a clinical study titled "Intensive Case Management Between VA and Community Care for Suicide Prevention". The goal of this randomized clinical trial is to build the evidence base for SUPERCEDE, a suicide prevention focused intensive case management intervention to increase access, improve care coordination, provide suicide prevention monitoring, and procure a timely response of VA mental health and suic...

What is the current status of trial NCT07534358?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-08-01. Estimated completion is 2027-06.

What interventions are being tested in trial NCT07534358?

The interventions under investigation include: SUicidE PRevention intensive CasE management and coorDination in Community CarE (SUPERCEDE) (BEHAVIORAL), Present centered therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT07534358?

This trial is sponsored by VA Eastern Colorado Health Care System, which has 42 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07534358's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07534358, the US trial registry maintained by the National Library of Medicine. NCT07534358 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.